Study Summary
This trial is testing whether a new treatment, narrow band ultraviolet B (NB-UVB) is better than the current standard treatment, psoralen with long wavelength ultraviolet A radiation (PUVA), for hand psoriasis/eczema.
Eligible Conditions
- Vitiligo
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Every four weeks up to 16 weeks, and at 24 weeks
Week 24
The primary endpoint will be based on the change in visual cutaneous symptoms as measured by the modified ASI score
Week 16
Adverse effects will be assessed every four weeks, including erythema, pruritus, and tanning. This will be assessed using the following scale: 0=none, 1=mild, 2=moderate, 3=severe.
Week 24
Hand
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Trial Design
2 Treatment Groups
Topical PUVA
1 of 2
NB-UVB
1 of 2
Active Control
30 Total Participants · 2 Treatment Groups
Primary Treatment: Topical PUVA · No Placebo Group · Phase 2
Topical PUVA
Device
ActiveComparator Group · 1 Intervention: Phototherapy · Intervention Types: DeviceNB-UVB
Device
ActiveComparator Group · 1 Intervention: Phototherapy · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: every four weeks up to 16 weeks, and at 24 weeks
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,325 Previous Clinical Trials
1,534,063 Total Patients Enrolled
4 Trials studying Vitiligo
95 Patients Enrolled for Vitiligo
Harvey Lui, MD, FRCPCPrincipal InvestigatorUniversity of British Columbia
3 Previous Clinical Trials
50 Total Patients Enrolled
3 Trials studying Vitiligo
50 Patients Enrolled for Vitiligo
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Individuals with chronic, symmetrical, severe hand psoriasis and eczema are those who have not responded to topical corticosteroid treatments
Subjects must be 18 years old or older.
Who else is applying?
What state do they live in?
| Tennessee | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| The Skin Care Center, Vancouver General Hospital | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments